Clinical Trial Update: Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating metastasis-directed therapy for oligoprogressive disease in men with castration-resistant prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Castration-resistant Prostate Cancer, Oligoprogressive | Phase 3 | Status: RECRUITING